How Telehealth is Changing Type 1 Diabetes Care
The type 1 community has always embraced new technology – with insulin pumps, CGM, and a whole range of T1D-focused apps rapidly becoming essential tools for many people.
It’s no surprise, then, that the T1D community has quickly adapted to new digital ways of accessing healthcare during the COVID-19 pandemic – what clinicians call telehealth.
Instead of seeing an endocrinologist or diabetes team face to face, consultations are now happening from people’s homes, over phone or video conferencing. Many people with T1D are finding telehealth to be a convenient and safe way of accessing their usual care. But what do healthcare professionals think? Are people with T1D really getting the same level of care through telehealth, and is this new way of doing things here to stay?
Telehealth has been a fixture of type 1 diabetes care in Australia for decades, helping people in rural or remote communities to access clinicians in larger centres. But it was only last month that the government temporarily expanded Medicare support for telehealth, allowing anyone to access certain health services from their own home.
Paediatric endocrinologist Prof Maria Craig says that the huge advances in CGM and pump technology over the past decade mean that people with T1D are well placed to benefit from telehealth.
“For most consultations, it’s just like being in the doctor’s office – I open up Tidepool or another app, I look at the data that’s in there, and we have a conversation about how things are going,” Prof Craig says. “As a clinician, whether it’s over the phone or face to face, the level of care I give someone is very similar.”
There are some limitations – people might not be able to accurately measure their height or weight at home, and it’s not possible do a physical examination or HbA1c test. But Prof Craig says that CGM and pump data include a wealth of information, and some of that can give clinicians a pretty good estimate of HbA1c.
And for families without a computer or a good internet connection, a phone call can be just as effective as a video call. If people don’t use CGM or would prefer to speak to someone face to face, they still have the option of a traditional consultation.
Kristine Heels, Nurse Manager of the Diabetes Clinical Service at The Children’s Hospital Westmead, says that telehealth is meant to work in tandem with face to face appointments, not replace them.
“In some cases, it’s still important to have face to face interaction – especially that initial education and support for newly diagnosed families,” Kristine says. “People shouldn’t be worried about coming in if they prefer it – even during a pandemic, the hospital is still one of the safest places to be.”
Changes for the better
Many people with T1D are finding that telehealth fits better with their lives than traditional appointments. It’s a safe and efficient way to have regular follow-ups, without the hassle and expense of travel, parking and waiting rooms.
There’s also been a big increase in the number of people who are sharing CGM data with their healthcare team electronically – something that clinicians have been encouraging for years. And video calls can even help clinicians get to know people a bit better.
“It’s been great to learn a bit more about people’s personalities and their lives at home than we normally would,” Kristine says. “There’s been cats jumping in front of the camera, or I’ll see a guitar or some beautiful art in the background that can spark a conversation – it helps strengthen the relationship we have with our patients, which is so important.”
Telehealth can also be great for family-centred care for children with T1D, as grandparents or parents living in separate homes are all able to share in the same conversation.
Is telehealth here to stay?
While telehealth is being used mostly out of necessity during the COVID-19 pandemic, Prof Craig hopes that in the future, we could see some more permanent changes around reimbursement.
“I think after this pandemic subsides, we might end up rethinking our models of care for T1D a bit,” Prof Craig says. “What we’ve seen now is that people of all ages are embracing telehealth, and while it might not be suitable in every case or every appointment, it can be a really efficient and effective tool for a large number of people.”
And while the current pandemic will eventually pass, viruses are here to stay. Prof Craig thinks that telehealth will be an important tool in preventing future outbreaks.
“If someone isn’t feeling well, they think they have a cold, we would prefer they stay at home rather than come into the hospital for their appointment,” Prof Craig says. “The same goes for doctors – they might previously have come in with a bit of a sniffle because they feel fit enough to work – but after this pandemic, we might start to rethink whether that’s appropriate.”
Kristine Heels agrees, and hopes that telehealth will continue to be used by diabetes teams in the future. “I think this pandemic has made us realise that there’s different ways of doing the things we’ve always done, and maybe these new ways end up suiting some people’s lives a little better.
Report: Aussie adults with type 1 diabetes unable to access life-changing technology due to high cost
Young adults and low-income families with type 1 diabetes (T1D) are facing immense barriers to using and retaining vital technology to manage their disease, with inequitable access and high costs putting them at risk of financial burden and life-threatening complications. The financial burden of managing T1D is exacerbating mental health issues with half of those […]
T1D Research Roundup: March 2021
Our research roundups bring you the most exciting T1D research stories from around the world – the new advances in treatment, devices and knowledge that are making the biggest impact in the fight to cure, treat and prevent T1D. Here’s what you need to know in T1D research this month: Monash University researchers crack the […]
COVID-19 Vaccines and T1D: Answering Your Questions
Australia has begun the rollout of two COVID-19 vaccines — one from Pfizer, and one from AstraZeneca. Both these vaccines are safe and effective at protecting people against COVID-19, and all Australians are encouraged to get vaccinated. With vaccines beginning to be offered to people with T1D, we’ve gathered all the information you need to […]
Top 10 T1D Research Breakthroughs of 2020
While COVID-19 has dominated the news in 2020, it’s also been a huge year for type 1 diabetes research. This year, we’ve made more progress than ever on our mission to cure, treat and prevent T1D – including new insights into what causes the disease, some incredible results from prevention therapies, and the launch of […]